TheNote
ViiV Healthcare announces new ... Note
GooglePlay AppStore
GSK press releases

ViiV Healthcare announces new implementation study data showing zero cases of HIV with Apretude, the only long-acting injectable approved for HIV PrEP

New data at CROI 2025 show zero cases of HIV acquisition reported with Apretude in varied clinical settings and populations.
https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-new-implementation-study-data-showing-zero-cases-of-hiv-with-apretude-the-only-long-acting-injectable-approved-for-hiv-prep/ gsk.com
RSS Hunter RSS Hunter • Mar 12, 2025

Cookies help us deliver our Services. By using our Services or clicking I agree, you agree to our use of cookies .